Unspecified contact dermatitis due to drugs in contact with skin
ICD-10 L25.1 is a billable code used to indicate a diagnosis of unspecified contact dermatitis due to drugs in contact with skin.
L25.1 refers to unspecified contact dermatitis due to drugs in contact with the skin. This condition manifests as an inflammatory response of the skin resulting from direct contact with a drug or chemical agent. Clinically, patients may present with symptoms such as erythema, pruritus, vesiculation, and in severe cases, ulceration. The anatomy involved primarily includes the epidermis and dermis, where the inflammatory process occurs. Disease progression can vary; it may resolve spontaneously upon removal of the offending agent or can become chronic if exposure continues. Diagnostic considerations include a thorough patient history to identify potential allergens, physical examination findings, and possibly patch testing to confirm the diagnosis. It is essential to differentiate L25.1 from other dermatitis types, such as allergic contact dermatitis (L23) or irritant contact dermatitis (L24), to ensure appropriate management and treatment.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L25.1 covers unspecified contact dermatitis due to drugs that come into contact with the skin. This includes reactions to topical medications, systemic drugs that cause skin reactions upon contact, and other chemical agents. Specific diagnostic criteria involve the identification of the drug exposure and the resultant skin reaction.
L25.1 should be used when the dermatitis is specifically due to drug exposure and the exact agent is unknown or unspecified. If the drug is known, codes from L23 or L24 may be more appropriate, depending on whether the reaction is allergic or irritant in nature.
Documentation for L25.1 should include a detailed patient history that identifies potential drug exposures, clinical findings from the physical examination, and any diagnostic tests performed, such as patch testing, to confirm the diagnosis.
